Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.87 USD | -5.56% | -10.95% | -87.30% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.30% | 134M | |
-5.99% | 84.46B | |
+2.76% | 40.85B | |
-24.88% | 27.69B | |
+53.61% | 24.28B | |
-8.08% | 17.09B | |
-33.74% | 13.67B | |
-16.63% | 11.86B | |
-11.19% | 11.79B | |
-2.25% | 8.07B |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Amylyx Pharmaceuticals Reports Narrowed Q3 Net Loss, Small Increase in Revenue